These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 4343629)

  • 41. Auto- and postsynaptic dopamine receptors in the central nervous system.
    Rebec GV
    Monogr Neural Sci; 1984; 10():207-23. PubMed ID: 6321971
    [No Abstract]   [Full Text] [Related]  

  • 42. Synaptic excitation in the corpus striatum inhibited by microelectrophoretically administered dopamine.
    Herz A; Zieglgänsberger W
    Experientia; 1966 Dec; 22(12):839-40. PubMed ID: 5973234
    [No Abstract]   [Full Text] [Related]  

  • 43. Studies on synaptic transmission using drugs as tools.
    McLennan H
    Triangle; 1971; 10(3):85-92. PubMed ID: 4333107
    [No Abstract]   [Full Text] [Related]  

  • 44. Postsynaptic supersensitivity after 6-hydroxy-dopamine induced degeneration of the nigro-striatal dopamine system.
    Ungerstedt U
    Acta Physiol Scand Suppl; 1971; 367():69-93. PubMed ID: 4332693
    [No Abstract]   [Full Text] [Related]  

  • 45. The use of rat atria as a simple and sensitive in vitro preparation for detecting pre-synaptic actions of drugs on adrenergic transmission [proceedings].
    Ddowu OA; Zar MA
    Br J Pharmacol; 1977 Sep; 61(1):157P. PubMed ID: 199309
    [No Abstract]   [Full Text] [Related]  

  • 46. Striatonigrostriatal circuit architecture for disinhibition of dopamine signaling.
    Ambrosi P; Lerner TN
    Cell Rep; 2022 Aug; 40(7):111228. PubMed ID: 35977498
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Monkeys with nigrostriatal lesions: tremor induced by harmaline and other drugs.
    Poirier LJ; Sourkes TL
    Pharmacol Ther B; 1976; 2(1):105-122. PubMed ID: 4828
    [No Abstract]   [Full Text] [Related]  

  • 48. FURTHER EVIDENCE FOR THE PRESENCE OF NIGRO-NEOSTRIATAL DOPAMINE NEURONS IN THE RAT.
    ANDEN NE; DAHLSTROEM A; FUXE K; LARSSON K
    Am J Anat; 1965 Jan; 116():329-33. PubMed ID: 14283289
    [No Abstract]   [Full Text] [Related]  

  • 49. Dose-dependent feeding in the rat following substantia nigra acetylcholinesterase blockade.
    Winn P; Redgrave P
    Eur J Pharmacol; 1981 Dec; 76(4):421-5. PubMed ID: 6276195
    [No Abstract]   [Full Text] [Related]  

  • 50. Inhibitory effects of substantia nigra on impulse transmission from nociceptors.
    Barnes CD; Fung SJ; Adams WL
    Pain; 1979 Apr; 6(2):207-215. PubMed ID: 37473
    [No Abstract]   [Full Text] [Related]  

  • 51. The action of some harmala alkaloids on transmission at a glutamate-mediated synapse.
    Dowson RJ; Clements AN; May TE
    Neuropharmacology; 1975 Mar; 14(3):235-40. PubMed ID: 166329
    [No Abstract]   [Full Text] [Related]  

  • 52. Effect of brain lesions and of harmaline on the DOPA decarboxylase activity in the striatum of the cat.
    Lancaster G; Larochelle L; Bédard P; Missala K; Sourkes TL; Poirier LJ
    J Neurol Sci; 1970 Sep; 11(3):265-74. PubMed ID: 5505688
    [No Abstract]   [Full Text] [Related]  

  • 53. The caudate spindle during various sleep stages.
    Sayers A; Stille G
    Experientia; 1972 Mar; 28(3):282-4. PubMed ID: 5026432
    [No Abstract]   [Full Text] [Related]  

  • 54. [Regulation of serotoninergic transmission in the basal ganglia].
    Héry F; Becquet D; Faudon M
    Encephale; 1989; 15 Spec No():127-32. PubMed ID: 2545432
    [No Abstract]   [Full Text] [Related]  

  • 55. Synaptic mechanisms in the substantia nigra.
    Dray A; Straughan DW
    J Pharm Pharmacol; 1976 Apr; 28(4 SUPPL):400-5. PubMed ID: 6745
    [No Abstract]   [Full Text] [Related]  

  • 56. Presynaptic regulation of dopamine release. Implications for the functional organization of the basal ganglia.
    Chesselet MF
    Ann N Y Acad Sci; 1990; 604():17-22. PubMed ID: 2171393
    [No Abstract]   [Full Text] [Related]  

  • 57. Effect of striatal and claustral stimulation upon spinal reflex and strychnine activity.
    SEGUNDO JP; MIGLIARO EF; ROIG JA
    J Neurophysiol; 1958 Jul; 21(4):391-9. PubMed ID: 13576182
    [No Abstract]   [Full Text] [Related]  

  • 58. Pre- and post-synaptic activities of some dopamine analogues and related compounds [proceedings].
    Brown RA; Brown RC; O'Connor SE; Solca AM
    Br J Pharmacol; 1979 Nov; 67(3):420P-421P. PubMed ID: 497548
    [No Abstract]   [Full Text] [Related]  

  • 59. Efficacy of striatal shocks in avian conditioned behaviors.
    TOWE AL
    Science; 1956 May; 123(3204):936-7. PubMed ID: 13324117
    [No Abstract]   [Full Text] [Related]  

  • 60. Does tetrahydroparaveroline contribute to the cardiovascular actions of dopamine?
    Halushka PV; Hoffmann PC
    Biochem Pharmacol; 1968 Sep; 17(9):1873-80. PubMed ID: 5688274
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.